PD-1 Inhibitors for Melanoma

March 24, 2015
Jason J. Luke, MD

Special Reports, Immunotherapy (Issue 5), Volume 5, Issue 1

Jason J. Luke, MD, assistant professor of medicine, The University of Chicago, discusses PD-1 inhibitors for the treatment of patients with melanoma.

Jason J. Luke, MD, assistant professor of medicine, The University of Chicago, discusses PD-1 inhibitors for the treatment of patients with melanoma.

<<<

View the entire Special Report on Immunotherapy